| Product Code: ETC7268884 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gambia PCR-based Infectious Diseases Market Overview |
3.1 Gambia Country Macro Economic Indicators |
3.2 Gambia PCR-based Infectious Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Gambia PCR-based Infectious Diseases Market - Industry Life Cycle |
3.4 Gambia PCR-based Infectious Diseases Market - Porter's Five Forces |
3.5 Gambia PCR-based Infectious Diseases Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Gambia PCR-based Infectious Diseases Market Revenues & Volume Share, By Infection, 2021 & 2031F |
3.7 Gambia PCR-based Infectious Diseases Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.8 Gambia PCR-based Infectious Diseases Market Revenues & Volume Share, By PCR Technology, 2021 & 2031F |
3.9 Gambia PCR-based Infectious Diseases Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.10 Gambia PCR-based Infectious Diseases Market Revenues & Volume Share, By Testing, 2021 & 2031F |
3.11 Gambia PCR-based Infectious Diseases Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Gambia PCR-based Infectious Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Gambia |
4.2.2 Growing awareness about the benefits of PCR-based diagnostics |
4.2.3 Government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in remote areas |
4.3.2 High cost associated with PCR-based testing |
4.3.3 Lack of skilled professionals for conducting PCR tests |
5 Gambia PCR-based Infectious Diseases Market Trends |
6 Gambia PCR-based Infectious Diseases Market, By Types |
6.1 Gambia PCR-based Infectious Diseases Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Tuberculosis PCR Test, 2021- 2031F |
6.1.4 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Hepatitis PCR Test, 2021- 2031F |
6.1.5 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Human Immunodeficiency Virus (HIV) PCR Test, 2021- 2031F |
6.1.6 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Influenza PCR Test, 2021- 2031F |
6.1.7 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Human Papilloma Virus (HPV) PCR Test, 2021- 2031F |
6.2 Gambia PCR-based Infectious Diseases Market, By Infection |
6.2.1 Overview and Analysis |
6.2.2 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Viral Infection, 2021- 2031F |
6.2.3 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Respiratory Tract Infection, 2021- 2031F |
6.2.4 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Sexually Transmitted Infection, 2021- 2031F |
6.2.5 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Hospital Acquired Infections, 2021- 2031F |
6.2.6 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Other Infections, 2021- 2031F |
6.3 Gambia PCR-based Infectious Diseases Market, By Pathogen |
6.3.1 Overview and Analysis |
6.3.2 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Viral, 2021- 2031F |
6.3.3 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Bacterial, 2021- 2031F |
6.3.4 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Fungal, 2021- 2031F |
6.3.5 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Protozoa, 2021- 2031F |
6.3.6 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Gambia PCR-based Infectious Diseases Market, By PCR Technology |
6.4.1 Overview and Analysis |
6.4.2 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By RT PCR, 2021- 2031F |
6.4.3 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Multiplex PCR, 2021- 2031F |
6.4.4 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Gambia PCR-based Infectious Diseases Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5.3 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5.4 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Adults, 2021- 2031F |
6.6 Gambia PCR-based Infectious Diseases Market, By Testing |
6.6.1 Overview and Analysis |
6.6.2 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Laboratory Based Testing, 2021- 2031F |
6.6.3 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Point of Care Testing, 2021- 2031F |
6.7 Gambia PCR-based Infectious Diseases Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.7.3 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7.4 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Community Health Centers, 2021- 2031F |
6.7.5 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Community Health Centers, 2021- 2031F |
6.7.6 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Clinics, 2021- 2031F |
6.7.7 Gambia PCR-based Infectious Diseases Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
7 Gambia PCR-based Infectious Diseases Market Import-Export Trade Statistics |
7.1 Gambia PCR-based Infectious Diseases Market Export to Major Countries |
7.2 Gambia PCR-based Infectious Diseases Market Imports from Major Countries |
8 Gambia PCR-based Infectious Diseases Market Key Performance Indicators |
8.1 Percentage increase in the number of PCR-based infectious disease tests conducted annually |
8.2 Adoption rate of PCR-based diagnostics in healthcare facilities across Gambia |
8.3 Average turnaround time for PCR test results |
9 Gambia PCR-based Infectious Diseases Market - Opportunity Assessment |
9.1 Gambia PCR-based Infectious Diseases Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Gambia PCR-based Infectious Diseases Market Opportunity Assessment, By Infection, 2021 & 2031F |
9.3 Gambia PCR-based Infectious Diseases Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.4 Gambia PCR-based Infectious Diseases Market Opportunity Assessment, By PCR Technology, 2021 & 2031F |
9.5 Gambia PCR-based Infectious Diseases Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.6 Gambia PCR-based Infectious Diseases Market Opportunity Assessment, By Testing, 2021 & 2031F |
9.7 Gambia PCR-based Infectious Diseases Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Gambia PCR-based Infectious Diseases Market - Competitive Landscape |
10.1 Gambia PCR-based Infectious Diseases Market Revenue Share, By Companies, 2024 |
10.2 Gambia PCR-based Infectious Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here